8 comparison of the effect of co-trimoxazole and co-trimoxazole plus ciprofloxacin in urinary tract infection prophylaxis in kidney transplant patients

9 Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: Case report and review of the literature.

10 Kidney transplantation from living donors with multiple renal arteries

11 Invasive pulmonary infection due to Thermoascus crustaceus in a kidney transplant recipient

12 Genetic diversity and antibiotic susceptibility of uropathogenic Escherichia coli isolates from kidney transplant recipients

13 Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections

14 Invasive pulmonary infection due to Thermoascus crustaceus in a kidney transplant recipient

15 Genetic diversity and antibiotic susceptibility of uropathogenic Escherichia coli isolates from kidney transplant recipients

16 Invasive pulmonary infection due to Thermoascus crustaceus in a kidney transplant recipient

17 Genetic diversity and antibiotic susceptibility of uropathogenic Escherichia coli isolates from kidney transplant recipients

18 Pros and Cons of Aspirin Prophylaxis for Prevention of Cardiovascular Events in Kidney Transplantation and Review of Evidence

19 Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections

20 Unusual Presentation of Hemophagocytic Lymphohistiocytosis in a Kidney Transplant Patient

21 Vectisol Formulation Enhances Solubility of Resveratrol and Brings Its Benefits to Kidney Transplantation in a Preclinical Porcine Model.

22 Acute Kidney Injury in Pregnant Patient With Pancreas-Kidney Transplant Caused by Abdominal Compartment Syndrome: A Case Presentation, Review of Literature, and Proposal of Diagnostic Approach.

23 Randomized Controlled Trial Assessing the Impact of Everolimus and Low Exposure Tacrolimus on Graft Outcomes in Kidney Transplant Recipients.

24 Decreased incidence of Kaposi sarcoma after kidney transplant in Italy and role of mTOR-inhibitors: 1997–2016

25 Proactive treatment of angiotensin receptor antibodies in kidney transplantation with plasma exchange and/or candesartan is safe and associated with excellent graft survival at 4 years: A single centre Australian experience

26 Effects of telmisartan and candesartan on the metabolism of lipids and glucose in kidney transplant patients: A prospective, randomized crossover study

27 Incidence of and risk factors for cryptococcosis in kidney transplant recipients in Taiwan- a nationwide population-based study.

28 Kidney transplantation. Experience at the University Hospital José E. González, UANL in Monterrey, Mexico

29 Machine learning in predicting graft failure following kidney transplantation: A systematic review of published predictive models.

30 Clinical features and burden of new onset diabetic foot ulcers post simultaneous pancreas kidney transplantation and kidney only transplantation

31 Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients

32 Life-threatening adenovirus infection in a kidney transplant recipient.

33 ULTRASOUND MONITORING IN THE EVALUATION OF THE FUNCTIONAL STATE OF A KIDNEY TRANSPLANT AT DIFFERENT IMMUNOSUPPRESSION THERAPIES

34 Cancer mortality in kidney transplant recipients: An Australian and New Zealand population-based cohort study, 1980-2013.

35 Long-term Clinical Significance of Tacrolimus Trough Level at the Early Period After Kidney Transplantation.

36 Effect on Dosage Change and Intrapatient Variability After Conversion From Twice-Daily to Once-Daily Tacrolimus Among Thai Kidney Transplant Patients With and Without CYP3A4/5 Inhibitors.

37 Model based development of tacrolimus dosing algorithm considering CYP3A5 genotypes and mycophenolate mofetil drug interaction in stable kidney transplant recipients

38 Optimal dose of everolimus administered with tacrolimus in living donor kidney transplantation

39 Therapeutic drug monitoring of cyclosporine and tacrolimus in Myanmar kidney transplant patients

40 Is There a Temporal Relationship Between Trough Whole Blood Tacrolimus Concentration and Acute Rejection in the First 14 Days After Kidney Transplantation?

41 Improving Access to Kidney Transplantation: Business as Usual or New Ways of Doing Business?

42 Association Between Dialysis Facility Ownership and Access to Kidney Transplantation.

43 Central venous catheter-related right atrial thrombus in two kidney transplantation recipients.

44 Quantitative PCR Of Indels To Measure Donor-Derived Cell-Free DNA - A Potential Method To Detect Acute Rejection In Kidney Transplantation.

45 Differences for T-Cell Subtypes in Aspiration Biopsies of Patients With Kidney Transplant Under Polyclonal and Monoclonal Immunosuppressive Treatments.

46 Effect of CYP3A5 genotype on hospitalization cost for kidney transplantation.

47 Analysis of NFATc1 amplification in T cells for pharmacodynamic monitoring of tacrolimus in kidney transplant recipients.

48 Early steroid withdrawal and optimization of mycophenolic acid exposure in kidney transplant recipients receiving mycophenolate mofetil.

49 Factors Related to International Travel for Transplantation Among U.S.-Listed Kidney Transplant Candidates.

50 Coinfection of Mycobacterium malmoense and Mycobacterium chimaera in a kidney transplant recipient: a case report and review of the literature.

51 Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: the 2019 Expert Consensus From the Transplant Society Working Group.

52 Amniotic fluid-derived mesenchymal stem cells prevent fibrosis and preserve renal function in a preclinical porcine model of kidney transplantation.

53 Assessment of 19 Genes and Validation of CRM Gene Panel for Quantitative Transcriptional Analysis of Molecular Rejection and Inflammation in Archival Kidney Transplant Biopsies

54 Data on a new biomarker for kidney transplant recipients: The number of FoxP3 regulatory T cells in the circulation.

55 Data on a new biomarker for kidney transplant recipients: The number of FoxP3 regulatory T cells in the circulation

56 Three-Year Outcomes of a Randomized, Double-Blind, Placebo-Controlled Study Assessing Safety and Efficacy of C1 Esterase Inhibitor for Prevention of Delayed Graft Function in Deceased Donor Kidney Transplant Recipients

57 Is warm ischemia not a risk factor for delayed graft function in a living-donor kidney transplant?

58 Cardiovascular Functional Reserve Before and After Kidney Transplant.

59 Does Sex, Race, and the Size of a Kidney Transplant Candidate's Social Network Affect the Number of Living Donor Requests? A Multi-Center Social Network Analysis of Patients on the Kidney Transplant Waitlist.

60 Rapid reduction of high-level pre-formed donor-specific antibodies after simultaneous liver-kidney transplantation: a report of two cases.

61 One-year Outcome of Everolimus With Standard-dose Tacrolimus Immunosuppression in De Novo ABO-incompatible Living Donor Kidney Transplantation: A Retrospective, Single-center, Propensity Score Matching Comparison With Mycophenolate in 42 Transplants.

62 Comparison of the effect of multimedia and booklet methods on quality of life of kidney transplant patients: A randomized clinical trial study

63 GSK-3β Inhibitor Induces Expression of the TLR4/MyD88/NF-κB Signaling Pathway to Protect Against Renal Ischemia-Reperfusion Injury During Rat Kidney Transplantation

64 Glycogen Synthase Kinase-3β Inhibitor Attenuates Renal Damage Through Regulating Antioxidant and Anti-inflammation in Rat Kidney Transplant With Cold Ischemia Reperfusion

65 Inactivation of IgM Antibodies as a Crucial Element of Diagnostics in Sensitized Patients Awaiting Kidney Transplant.

66 A Case of Successful Treatment of Severe COVID-19 Pneumonia with Favipiravir and Tocilizumab in Post-kidney Transplant Recipient.

67 Erectile Dysfunction after Kidney Transplantation

68 bk virus-associated nephropathy without viremia in an adolescent kidney transplant recipient

69 a randomized controlled trial of a mobile clinical decision aid to improve access to kidney transplantation: ichoose kidney

70 psychological rejection of the transplanted organ and graft dysfunction in kidney transplant patients

71 intestinal fungal and parasitic infections in kidney transplant recipients: a multi-center study

72 the effect of cold ischemia time on delayed graft function and acute rejection in kidney transplantation

73 fatal disseminated strongyloidiasis after kidney transplantation

74 implication of thymoglobulin in kidney transplant patients: review article

75 prospective changes in health-related quality of life and emotional outcomes in kidney transplantation over 6 years

76 gingival status of kidney transplanted patients referred to shariati general hospital, tehran

77 surgical illustration of en-bloc (dual) kidney transplant from a 16-month old brain-dead donor to an adult recipient

78 incidence and clinical significance of de novo donor specific antibodies after kidney transplantation

79 co-administration of ketoconazole and tacrolimus to kidney transplant recipients: cost minimization and potential metabolic benefits

80 anemia control in kidney transplant recipients using once-monthly continuous erythropoietin receptor activator: a prospective, observational study

81 outcome of recipients of human leukocyte antigen incompatible kidney transplants who underwent desensitization at king fahad specialist hospital, dammam, saudi arabia

82 the kidney transplant evaluation process in the elderly: reasons for being turned down and opportunities to improve cost-effectiveness in a single center

83 a case of continuous negative pressure wound therapy for abdominal infected lymphocele after kidney transplantation

84 multicolor flow cytometry and cytokine analysis provides enhanced information on kidney transplant biopsies

85 arterial reconstruction with donor iliac vessels during kidney transplantation in a patient with severe atherosclerosis

86 endovascular repair of an aorto-iliac aneurysm succeeded by kidney transplantation tratamento endovascular de aneurisma aorto-ilíaco sucedido por transplante renal

87 assessing consensus between uk renal clinicians on listing for kidney transplantation: a modified delphi study

88 successful treatment of focal segmental glomerulosclerosis after kidney transplantation with plasma exchange and abatacept in a patient with juvenile rheumatoid arthritis

89 genetic factors in pathogenesis of diabetes mellitus after kidney transplantation

90 direct and indirect effects of cytomegalovirus-induced gamma-delta t cells after kidney transplantation

91 a comprehensive analysis of the current status and unmet needs in kidney transplantation in southeast asia

92 histiocytic sarcoma in a kidney transplant patient: a case report and review of the literature

93 the kinetics of anti-hla antibodies in the first year after kidney transplantation: in whom and when should they be monitored?

94 angiosarcoma at the site of nonfunctioning arteriovenous fistula in a kidney transplant recipient

95 plasma nitration of high-density and low-density lipoproteins in chronic kidney disease patients receiving kidney transplants

96 immune response following liver transplantation compared to kidney transplantation: usefulness of monitoring peripheral blood cd4+ adenosine triphosphate activity and cytochrome p450 3a5 genotype assay

97 combined liver and kidney transplantation in two women with primary hyperoxaluria: different roads led to different outcomes

98 color doppler indexes in early phase after kidney transplantation and their association with kidney function on six month follow up

99 the interplay between inflammation and fibrosis in kidney transplantation

100 transplante renal em pacientes infectados pelo hiv kidney transplantation in hiv infected patients

101 kidney-paired donation to increase living donor kidney transplantation in india: guidelines of indian society of organ transplantation – 2017

Keyword Connections

Journals

Research Groups

Bibliographies